ANI Pharmaceuticals Inc (ANIP)

Return on assets (ROA)

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net income	US$ in thousands	-18,522	18,779	-47,896	-42,603	-22,548
Total assets	US$ in thousands	1,283,700	904,422	760,087	771,598	461,190
ROA		-1.44%	2.08%	-6.30%	-5.52%	-4.89%

December 31, 2024 calculation

ROA = Net income ÷ Total assets
= $-18,522K ÷ $1,283,700K
= -1.44%

The return on assets (ROA) for ANI Pharmaceuticals Inc has shown a fluctuating trend over the past five years. As of December 31, 2020, the ROA was -4.89%, indicating that the company was generating a negative return on its assets. This negative trend persisted in the subsequent years, with ROA figures of -5.52% in 2021 and -6.30% in 2022, suggesting a decline in the company's ability to generate profit relative to its total assets.

However, there was a notable improvement in the company's performance in 2023, with the ROA increasing to 2.08%. This uptick indicates that ANI Pharmaceuticals Inc was able to generate a positive return on its assets during that year, signaling a potential turnaround in its profitability and asset utilization.

Unfortunately, the positive momentum was not sustained, as the ROA decreased to -1.44% by December 31, 2024, indicating a return to generating negative returns relative to its assets. Overall, the ROA trend for ANI Pharmaceuticals Inc has been mixed, with periods of negative performance interspersed with brief instances of positive returns.